Abstract:Nucleic acid aptamers are oligonucleotide chains with molecular recognition properties. Compared with antibodies, aptamers show advantages given that they are readily produced via chemical synthesis and elicit minimal immunogenicity in biomedicine applications. Notably, aptamer-encoded nucleic acid assemblies further improve the binding affinity of aptamers with the targets due to their multivalent synergistic interactions. Specially, aptamers can be engineered with special topological arrangements in nucleic acid assemblies, which demonstrate spatial and valence matching towards antigens on viruses, thus showing potential in the detection and therapeutic applications of viruses. This review presents the recent progress on the aptamers explored for SARS-CoV-2 detection and infection treatment, wherein applications of aptamer-based assembly systems are introduced in detail. Screening methods and chemical modification strategies for aptamers are comprehensively summarized, and the types of aptamers employed against different target domains of SARS-CoV-2 are illustrated. The evolution of aptamer-based assembly systems for the detection and neutralization of SARS-CoV-2, as well as the construction principle and characteristics of aptamer-based DNA assemblies are demonstrated. The typically representative works are presented to demonstrate how to assemble aptamers rationally and elaborately for specific applications in SARS-CoV-2 diagnosis and neutralization. Finally, we provide deep insights into the current challenges and future perspectives towards aptamer-based nucleic acid assemblies for virus detection and neutralization in nanomedicine.

Aptamer‐ased Strategies Against SARS‐CoV‐2 Viruses (3/2023)

Aptamer‐based Strategies Against SARS‐CoV‐2 Viruses

Aptamers Targeting SARS-COV-2: a Promising Tool to Fight Against COVID-19.

Aptamer-based assembly systems for SARS-CoV-2 detection and therapeutics

Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Novel Insights into the Role of Aptamers in the Fight Against Cancer.

Aptamer Blocking Strategy Inhibits SARS‐CoV‐2 Virus Infection

Robust Covalent Aptamer Strategy Enables Sensitive Detection and Enhanced Inhibition of SARS-CoV-2 Proteins

Perspectives and Prospects on the application of DNA Aptamer in SARS-CoV-2

In silico selection of aptamers against SARS-CoV-2

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

Broadly neutralizing aptamers to SARS-CoV-2: a diverse panel of modified DNA antiviral agents

Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications

Molecular Mechanism of Interaction Between DNA Aptamer and Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Revealed by Steered Molecular Dynamics Simulations

Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

High Mannose-Specific Aptamers for Broad-Spectrum Virus Inhibition and Cancer Targeting

Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2

Diverse SARS-CoV-2 Aptamers Overcome Variant Antigenic Shift.

Aptamer-based Biosensors for Virus Protein Detection

Aptamers: The Powerful Molecular Tools for Virus Detection

Cover Feature: Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers (chem. Eur. J. 12/2022)